4//SEC Filing
SALIX PHARMACEUTICALS LTD 4
Accession 0001209191-13-022182
CIK 0001009356operating
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 6:06 PM ET
Size
7.3 KB
Accession
0001209191-13-022182
Insider Transaction Report
Form 4
KEANE WILLIAM P
Director
Transactions
- Award
Common Stock
2013-04-18$48.70/sh+4,110$200,157→ 37,312 total
Holdings
- 15,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (15,000 underlying) - 22,500
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (22,500 underlying)
Footnotes (2)
- [F1]Represents a restricted stock award which vests in its entirety on the earlier of July 1, 2014 or immediately prior to the 2014 Annual Stockholder meeting, subject to continued service as a director.
- [F2]Options are 100% vested.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001009356
Filing Metadata
- Form type
- 4
- Filed
- Apr 21, 8:00 PM ET
- Accepted
- Apr 22, 6:06 PM ET
- Size
- 7.3 KB